|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/70 | (2006.01) |
| (11) | Number of the document | 2898887 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14198829.5 |
| Date of filing the European patent application | 2007-10-30 | |
| (97) | Date of publication of the European application | 2015-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation | 2018-11-12 |
| (30) | Number | Date | Country code |
| 855583 P | 2006-10-30 | US |
| (72) |
Go, Ning, US
Tressler, Robert J., US
|
| (73) |
GERON CORPORATION,
149 Commonwealth Drive, Menlo Park, CA 94025,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Telomerazės inhibitoriaus ir gemcitabino derinys vėžio gydymui |
| COMBINED TELOMERASE INHIBITOR AND GEMCITABINE FOR THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-09-23 | 18 | 347.00 EUR |
| 2025-10-30 |